Literature DB >> 22425819

Cyclosporine treatment improves cardiac function and systemic hemodynamics during resuscitation in a newborn piglet model of asphyxia: a dose-response study.

Richdeep S Gill1, Namdar Manouchehri, Jiang-Qin Liu, Tze-Fun Lee, Woo Jung Cho, Aducio Thiesen, Thomas Churchill, David Bigam, Po-Yin Cheung.   

Abstract

OBJECTIVES: Asphyxiated neonates often have myocardial depression, which is a significant cause of morbidity and mortality. Cardioprotective effects of cyclosporine have been observed in adult patients and animals with myocardial infarction. However, the cardioprotective effect of cyclosporine in neonates has not yet been studied. We hypothesize that cyclosporine will improve cardiac function and reduce myocardial injury in asphyxiated newborn piglets.
DESIGN: Thirty-six piglets (1-4 days old, weighing 1.4-2.5 kg) were acutely instrumented for continuous monitoring of cardiac output and systemic arterial pressure. After stabilization, normocapnic alveolar hypoxia (10% to 15% oxygen) was instituted for 2 hrs followed by reoxygenation with 100% oxygen for 0.5 hrs and then 21% for 3.5 hrs. A nonasphyxiated, sham-operated group was included (n = 4) to control for effects of the surgical model. Plasma troponin and myocardial lactate concentrations were determined as well as morphologic examinations.
SETTING: Neonatal asphyxia and reoxygenation.
SUBJECTS: Newborn (1-4 days old) piglets.
INTERVENTIONS: Piglets were block-randomized to receive intravenous boluses of cyclosporine A (2.5, 10, or 25 mg/kg) or normal saline (control) at 5 mins of reoxygenation (n = 8/group).
MEASUREMENTS AND MAIN RESULTS: Cardiac index, heart rate, systemic oxygenation, plasma troponin, and left ventricular lactate were measured. Hypoxic piglets had cardiogenic shock (cardiac output 40% to 48% of baseline), hypotension (mean arterial pressure 27-31 mm Hg), and acidosis (pH 7.04). Cyclosporine treatment caused bell-shaped improvements in cardiac output, stroke volume, and systemic oxygen delivery (p < .05 vs. controls). Plasma troponin and left ventricle lactate were higher in controls than that of 2.5 and 10 mg/kg cyclosporine-treated groups (p < .05). Although histologic features of myocardial injury were not different among groups, severe damage was observed in mitochondria of control piglets but attenuated in that of cyclosporine (10 mg/kg) treatment.
CONCLUSIONS: Postresuscitation administration of cyclosporine causes preservation of cardiac function and attenuates myocardial injury in newborn piglets after asphyxia-reoxygenation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425819     DOI: 10.1097/CCM.0b013e3182387d2b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

Review 1.  Novelties in pharmacological management of cardiopulmonary resuscitation.

Authors:  Jason A Bartos; Demetris Yannopoulos
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

2.  Cyclosporine A cardioprotection: mechanisms and potential for clinical application.

Authors:  Rolf Bünger; Robert T Mallet
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

3.  Early versus delayed cyclosporine treatment in cardiac recovery and intestinal injury during resuscitation of asphyxiated newborn piglets.

Authors:  Richdeep S Gill; Tze-Fun Lee; Consolato Sergi; David L Bigam; Po-Yin Cheung
Journal:  Intensive Care Med       Date:  2012-05-10       Impact factor: 17.440

Review 4.  ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies.

Authors:  Sandrine Lecour; Hans E Bøtker; Gianluigi Condorelli; Sean M Davidson; David Garcia-Dorado; Felix B Engel; Peter Ferdinandy; Gerd Heusch; Rosalinda Madonna; Michel Ovize; Marisol Ruiz-Meana; Rainer Schulz; Joost P G Sluijter; Linda W Van Laake; Derek M Yellon; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2014-10-24       Impact factor: 10.787

5.  Intra-Arrest Administration of Cyclosporine and Methylprednisolone Does Not Reduce Postarrest Myocardial Dysfunction.

Authors:  Meshe Chonde; Katharyn L Flickinger; Matthew L Sundermann; Allison C Koller; David D Salcido; Cameron Dezfulian; James J Menegazzi; Jonathan Elmer
Journal:  Biomed Res Int       Date:  2019-06-11       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.